MLH1 and colorectal carcinoma: Considering the challenges in functionally characterizing these aspects in human models, we exploited a well-characterized isogenic murine CRC model in which we previously perturbed MMR proficiency through Mlh1 gene knock-out with the CRISPR/Cas9 technology [10].